AI MARKET SCANNING

ProQR Therapeutics NV

📅 Next Catalyst: Nov 05, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -0.11%
MAX GAP RECORD +3.85%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $PRQR
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN)
+2.15%
May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN)
-0.62%
Mar 12, 2026 Earnings Release 2026-03-12 (BEFORE OPEN)
+0.00%
Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN)
-2.94%
Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN)
+0.00%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+3.85%
Mar 12, 2025 Earnings Release 2025-03-12 (AFTER CLOSE)
-2.16%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.1%
Bullish Gaps (4)
Bearish Gaps (6)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $PRQR

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗